Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Lung cancer is one of the leading causes of cancer-related death. Lung cancer mortality has decreased over the past decade, which is partly attributed to improved treatments. Curative surgery for patients with early-stage lung cancer is the standard of care, but not all surgical treatments have a go...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yurong Peng, Zhuo Li, Yucheng Fu, Yue Pan, Yue Zeng, Junqi Liu, Chaoyue Xiao, Yingzhe Zhang, Yahui Su, Guoqing Li, Fang Wu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-01-01
Col·lecció:	Frontiers in Oncology
Matèries:	perioperative period perioperative immunotherapy neoadjuvant therapies immunotherapy neoadjuvant immune monotherapy adjuvant therapy biomarkers
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1011810/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!